- Home
- UE vs RARE Comparison
UE vs RARE Comparison
Compare UE & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UE
- RARE
- Stock Information
- Founded
- UE 2014
- RARE 2010
- Country
- UE United States
- RARE United States
- Employees
- UE 109
- RARE N/A
- Industry
- UE Real Estate
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- UE Finance
- RARE Health Care
- Exchange
- UE Nasdaq
- RARE Nasdaq
- Market Cap
- UE 2.4B
- RARE 2.6B
- IPO Year
- UE N/A
- RARE 2014
- Fundamental
- Price
- UE $19.04
- RARE $28.44
- Analyst Decision
- UE Hold
- RARE Strong Buy
- Analyst Count
- UE 1
- RARE 16
- Target Price
- UE $22.00
- RARE $86.94
- AVG Volume (30 Days)
- UE 1.1M
- RARE 3.3M
- Earning Date
- UE 07-30-2025
- RARE 08-05-2025
- Dividend Yield
- UE 3.99%
- RARE N/A
- EPS Growth
- UE N/A
- RARE N/A
- EPS
- UE 0.84
- RARE N/A
- Revenue
- UE $461,043,000.00
- RARE $590,689,000.00
- Revenue This Year
- UE $6.36
- RARE $18.70
- Revenue Next Year
- UE $4.00
- RARE $26.76
- P/E Ratio
- UE $22.57
- RARE N/A
- Revenue Growth
- UE 8.59
- RARE 33.46
- 52 Week Low
- UE $15.66
- RARE $25.81
- 52 Week High
- UE $23.85
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- UE 46.31
- RARE 40.47
- Support Level
- UE $19.45
- RARE $26.85
- Resistance Level
- UE $20.90
- RARE $28.48
- Average True Range (ATR)
- UE 0.46
- RARE 1.23
- MACD
- UE -0.02
- RARE 0.19
- Stochastic Oscillator
- UE 16.74
- RARE 74.08
About UE Urban Edge Properties of Beneficial Interest
Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.